NYSE · Healthcare · Medical Devices · USA
Butterfly Network Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
Butterfly Network develops portable ultrasound devices based on its proprietary Ultrasound-on-Chip semiconductor platform, combining hardware, software, and educational services for point-of-care applications. The company markets its devices to healthcare systems, physicians, and providers through direct sales, distributors, and e-commerce channels across multiple countries. Butterfly also licenses its semiconductor platform for co-development in non-medical applications.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Butterfly Network Inc stock.
Overvalued: intrinsic value $0.72 per share, market price $7.31, margin of safety -920.2% (as of 2026-10-20).
A 0.8x revenue multiple, discounted for its losses, values the shares at $0.72; the price of $7.31 is 920% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
58 more in this industry show a wider margin of safety.
BFLY is overvalued (as of the 2026-10-20 close). A 0.8x revenue multiple, discounted for its losses, values the shares at $0.72; the price of $7.31 is 920% above that value.
$0.72 per share (as of the 2026-10-20 close), against a market price of $7.31. That is a margin of safety of -920.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.